Steven I Sherman - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Steven I Sherman

Showing results (131-140 of 160) with videos related to

Pageof 16

Sort By:

Hepatology (Baltimore, Md.)|April 29, 2009

Association between hypothyroidism and hepatocellular carcinoma: a case-control study in the United StatesManal M Hassan, Ahmed Kaseb, Donghui Li, et al.

The Journal of Clinical Endocrinology and Metabolism|July 15, 2015

Long-Term Outcomes Following Therapy in Differentiated Thyroid Carcinoma: NTCTCS Registry Analysis 1987-2012Aubrey A Carhill, Danielle R Litofsky, Douglas S Ross, et al.

Thyroid : Official Journal of the American Thyroid Association|October 15, 2015

2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid CancerBryan R Haugen, Erik K Alexander, Keith C Bible, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 12, 2009

Phase I trial of a combination of the multikinase inhibitor sorafenib and the farnesyltransferase inhibitor tipifarnib in advanced malignanciesDavid S Hong, Said M Sebti, Robert A Newman, et al.

Thyroid : Official Journal of the American Thyroid Association|July 24, 2015

Reassessing the NTCTCS Staging Systems for Differentiated Thyroid Cancer, Including Age at DiagnosisDonald S A McLeod, Jacqueline Jonklaas, James D Brierley, et al.

Thyroid : Official Journal of the American Thyroid Association|January 25, 2017

American Thyroid Association Guidelines on the Management of Thyroid Nodules and Differentiated Thyroid Cancer Task Force Review and Recommendation on the Proposed Renaming of Encapsulated Follicular Variant Papillary Thyroid Carcinoma Without Invasion to Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear FeaturesBryan R Haugen, Anna M Sawka, Erik K Alexander, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2011

Activity of XL184 (Cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancerRazelle Kurzrock, Steven I Sherman, Douglas W Ball, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 5, 2013

Cabozantinib in progressive medullary thyroid cancerRossella Elisei, Martin J Schlumberger, Stefan P Müller, et al.

The Journal of Clinical Endocrinology and Metabolism|September 24, 2016

Bone Metastases and Skeletal-Related Events in Medullary Thyroid CarcinomaJian Yu Xu, William A Murphy, Denái R Milton, et al.

Biorxiv : the Preprint Server for Biology|August 12, 2025

Activating <i>RET</i> Mutations Promotes Osteoblastic Bone Metastases in Medullary Thyroid CancerRozita Bagheri-Yarmand, Gabriel M Pagnotti, Joseph L Kidd, et al.

Pageof 16

Search research articles

Showing results (131-140 of 160) with videos related to

Sort By:

Pageof 16

Hepatology (Baltimore, Md.)|April 29, 2009

Association between hypothyroidism and hepatocellular carcinoma: a case-control study in the United StatesManal M Hassan, Ahmed Kaseb, Donghui Li, et al.

The Journal of Clinical Endocrinology and Metabolism|July 15, 2015

Long-Term Outcomes Following Therapy in Differentiated Thyroid Carcinoma: NTCTCS Registry Analysis 1987-2012Aubrey A Carhill, Danielle R Litofsky, Douglas S Ross, et al.

Thyroid : Official Journal of the American Thyroid Association|October 15, 2015

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 12, 2009

Phase I trial of a combination of the multikinase inhibitor sorafenib and the farnesyltransferase inhibitor tipifarnib in advanced malignanciesDavid S Hong, Said M Sebti, Robert A Newman, et al.

Thyroid : Official Journal of the American Thyroid Association|July 24, 2015

Reassessing the NTCTCS Staging Systems for Differentiated Thyroid Cancer, Including Age at DiagnosisDonald S A McLeod, Jacqueline Jonklaas, James D Brierley, et al.

Thyroid : Official Journal of the American Thyroid Association|January 25, 2017

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2011

Activity of XL184 (Cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancerRazelle Kurzrock, Steven I Sherman, Douglas W Ball, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 5, 2013

Cabozantinib in progressive medullary thyroid cancerRossella Elisei, Martin J Schlumberger, Stefan P Müller, et al.

The Journal of Clinical Endocrinology and Metabolism|September 24, 2016

Bone Metastases and Skeletal-Related Events in Medullary Thyroid CarcinomaJian Yu Xu, William A Murphy, Denái R Milton, et al.

Biorxiv : the Preprint Server for Biology|August 12, 2025

Activating <i>RET</i> Mutations Promotes Osteoblastic Bone Metastases in Medullary Thyroid CancerRozita Bagheri-Yarmand, Gabriel M Pagnotti, Joseph L Kidd, et al.

Pageof 16